2nd Day-2nd Talk: “Stem Cell Therapy for the Treatment of Cardiovascular Disease” by Nabil Dib, MD

Dr. Nabil Dib was the Principal Investigator for a Phase I clinical trial in which stem cells from a patient's thigh muscle were delivered, using a catheter, to the damaged heart tissue. The Food and Drug Administration approved an expanded study involving 160 patients. Dr. Dib is also the Director of Clinical Cardiovascular Cell Therapy at the University of California, San Diego.

Coming...